Japan's PeptiDream to work with Merck in developing COVID-19 therapies

Japan's PeptiDream to work with Merck in developing COVID-19 therapies
Reuters: Health
Japanese drug-discovery company PeptiDream Inc said on Friday it would collaborate with Merck & Co in developing COVID-19 therapies.